Li, C., Zhu, J., Cheng, F., Yu, W., Chen, Z., Song, C., Zhu, H., Li, H. (2025). Effectiveness and safety of RC48-ADC in combination with toripalimab as neoadjuvant treatment in HER2-positive muscular invasive urothelial bladder cancer patients.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.710